[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"article-CSN-051126128--":3,"related-articles-undefined-undefined-3b0c143a-1ddd-4edc-8eae-c9192ac88aac-true":15},{"id":4,"type":5,"title":6,"pubDate":7,"logoUrl":8,"anpFeedCategory":9,"organisationTitle":10,"thirdParty":11,"body":12,"orgId":13,"description":14},"CSN-051126128","PRESSRELEASE"," ABEC Launches ATB™-2100 Platform to Transform Advanced Therapy Manufacturing","2026-11-05T16:12:25.000+01:00","https:\u002F\u002Fwww.persberichten.nl\u002Fimg\u002Fpr-newswire.png","Economie","PR Newswire",true,"\u003Cp> \nBETHLEHEM, Pa., Nov. 5, 2026 \u002FPRNewswire\u002F -- ABEC, a global leader in engineered solutions and services for biopharmaceutical manufacturing, today announced the commercial launch of the ATB™-2100 Advanced Therapy Bioreactor, a breakthrough single-use cell expansion technology designed to address the cell and gene therapy industry's growing need for scalable, reproducible, and automated manufacturing.\u003C\u002Fp>\u003Cp> \n    \n                \n                    \n                \n    \nThe ATB™-2100 represents a new approach to advanced therapy processing, combining unprecedented process control and scalability in a fully-closed and automated platform that supports cell expansion from preclinical development through commercial manufacturing. Designed for the most difficult cell and gene therapy applications, the platform has successfully demonstrated the expansion of T-cells, induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), and other emerging modalities.\u003C\u002Fp>\u003Cp> At the core of the ATB™-2100 is ABEC's proprietary network of hollow-fiber perfusion membranes, which continuously deliver nutrients and gases throughout the culture environment while removing metabolic waste. The system emulates the human circulatory system with a diffusion-based, low-shear environment that is ideal for cell growth. Exceptionally high cell densities and viabilities are achieved because cells are not exposed to the stresses commonly associated with other platforms.\u003C\u002Fp>\u003Cp> Unlike other cell expansion technologies that require process redevelopment during scale-up, the ATB™ platform maintains a consistent membrane surface-area-to-volume ratio across bioreactor volumes from 200mL to 10L, enabling direct translation of process conditions from early-stage development through commercial production. This unique scalability significantly reduces development timelines, minimizes risk during technology transfer, and reduces time to market.\u003C\u002Fp>\u003Cp> \"Cell and gene therapies continue to face significant development and manufacturing challenges that limit scalability, increase costs, and slow commercialization,\" said Scott Pickering, Chief Executive Officer of ABEC. \"The ATB™-2100 overcomes these barriers and represents another industry-changing advancement pioneered by ABEC.\"\u003C\u002Fp>\u003Cp> For more information about the ATB™-2100 Advanced Therapy Bioreactor Platform, visit \u003Ca target=\"_blank\" href=\"https:\u002F\u002Fedge.prnewswire.com\u002Fc\u002Flink\u002F?t=0&l=en&o=4814688-1&h=1724363408&u=https%3A%2F%2Fwww.abec.com%2F&a=www.abec.com\">www.abec.com\u003C\u002Fa> or contact \u003Ca target=\"_blank\" href=\"mailto:info@abec.com\">info@abec.com.\u003C\u002Fa>\u003C\u002Fp>\u003Cp> About ABEC\u003C\u002Fp>\u003Cp> ABEC is a leading global provider of engineered solutions and services for biopharmaceutical manufacturing. With more than 50 years of innovation, ABEC combines bioprocess equipment expertise, engineering, manufacturing, automation, and services to support the development and commercialization of life-changing therapies. From R&D through commercial implementation and lifecycle support, ABEC delivers innovative solutions that enhance productivity, accelerate time to market, and reduce overall cost to enable manufacturing success around the world.\u003C\u002Fp>\u003Cp> \u003C\u002Fp>\u003Cp> \u003C\u002Fp>\u003Cp>  View original content to download multimedia:https:\u002F\u002Fwww.prnewswire.co.uk\u002Fnews-releases\u002Fabec-launches-atb-2100-platform-to-transform-advanced-therapy-manufacturing-302929978.html\u003C\u002Fp>","3b0c143a-1ddd-4edc-8eae-c9192ac88aac","BETHLEHEM, Pa., Nov. 5, 2026 \u002FPRNewswire\u002F -- ABEC, a global leader in engineered solutions and services for biopharmaceutical manufacturing, today announced the",[16,21,26,27,32,37,42,47,52,57],{"id":17,"title":18,"pubDate":19,"logoUrl":8,"thirdParty":11,"orgId":13,"description":20},"CSN-051126181"," Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook","2026-11-05T22:02:24.000+01:00","- Third-Quarter Revenue Grew 233% Year-Over-Year; Raised FY2026 Revenue Outlook - Extended Fault-Tolerance Industry Leadership with Back-to-Back World Records, ",{"id":22,"title":23,"pubDate":24,"logoUrl":8,"thirdParty":11,"orgId":13,"description":25},"CSN-051126134"," Global Experience Specialists Announces Acquisition of CSG Creative from National Trade Productions, Inc.","2026-11-05T16:31:25.000+01:00","Acquisition brings strategic marketing expertise, creative excellence and an experienced leadership team to GES, creating new opportunities to drive growth and ",{"id":4,"title":6,"pubDate":7,"logoUrl":8,"thirdParty":11,"orgId":13,"description":14},{"id":28,"title":29,"pubDate":30,"logoUrl":8,"thirdParty":11,"orgId":13,"description":31},"CSN-051126126"," Beelink ME Pro Launches on Kickstarter With an Innovative Swappable Motherboard Design for Easier NAS Upgrades","2026-11-05T16:01:25.000+01:00","SHENZHEN, China, Nov. 5, 2026 \u002FPRNewswire\u002F -- Beelink today announced the Kickstarter launch of the ME Pro, a modular NAS available in two-bay and four-bay conf",{"id":33,"title":34,"pubDate":35,"logoUrl":8,"thirdParty":11,"orgId":13,"description":36},"CSN-051126121"," LITEON Powers AI from Cloud to Edge at electronica 2026","2026-11-05T15:26:26.000+01:00","MUNICH, Nov. 5, 2026 \u002FPRNewswire\u002F -- LITEON Technology heads to electronica 2026 in Munich from November 10 to 13 under the theme \"LITEON Powers AI.\" Across its",{"id":38,"title":39,"pubDate":40,"logoUrl":8,"thirdParty":11,"orgId":13,"description":41},"CSN-051126112"," Supermicro lanceert samen met IBM en NVIDIA een KV-cacheoplossing die aanzienlijke prestatievoordelen bij AI-inferentie oplevert","2026-11-05T15:06:25.000+01:00","- De KV-cacheoplossing (key-value-cache) integreert Supermicro Petascale-opslagservers, IBM Storage Scale-software, NVIDIA Dynamo-inferentiesoftware en NVIDIA S",{"id":43,"title":44,"pubDate":45,"logoUrl":8,"thirdParty":11,"orgId":13,"description":46},"CSN-051126111"," Center for Creative Leadership Names Patrick Mullane President and Chief Executive Officer","2026-11-05T15:05:24.000+01:00","Former head of Harvard Business School Online & Executive Education to lead CCL's next phase of growth GREENSBORO, N.C., Nov. 5, 2026 \u002FPRNewswire\u002F -- The Center",{"id":48,"title":49,"pubDate":50,"logoUrl":8,"thirdParty":11,"orgId":13,"description":51},"CSN-051126096"," Quantinuum Unveils Nexus Roadmap to Deliver the First Developer Platform Designed for the Fault-Tolerant Quantum Era","2026-11-05T14:01:24.000+01:00","- Roadmap connects application development and deployment with each generation of Quantinuum hardware through Apollo, its universal, fault-tolerant quantum comp",{"id":53,"title":54,"pubDate":55,"logoUrl":8,"thirdParty":11,"orgId":13,"description":56},"CSN-051126094"," DJI Matrice 5T Uplevels Intelligent Aerial Operations, Day or Night for Challenging Missions","2026-11-05T13:52:25.000+01:00","New IP55-Rated Matrice 5T Enterprise Drone Integrates LiDAR, mmWave radar, Vision Sensing Alongside 1K Thermal Imaging and Enhanced Night Vision SHENZHEN,China,",{"id":58,"title":59,"pubDate":60,"logoUrl":8,"thirdParty":11,"orgId":13,"description":61},"CSN-051126065"," Nine Months 2026 Trading Update","2026-11-05T11:42:24.000+01:00","Delivering Strategic Progress and Strengthening Growth Prospects ATHENS, Greece and LONDON, Nov. 5, 2026 \u002FPRNewswire\u002F -- METLEN Energy & Metals PLC (LSE Listing"]